FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Cytokinetics Reports Exercise Data on Heart Drug

Cytokinetics reports topline results from its Phase 3 MAPLE-HCM clinical trial showing that aficamten significantly improved exercise capacity in pati...

latest-news-card-1
Human Drugs

Hunter Syndrome Gene Therapy Accepted for Review

FDA accepts for priority review a Regenxbio BLA seeking accelerated approval for gene therapy RGX-121 (clemidsogene lanparvovec) for treating Hunter s...

Animal Drugs

Taizhou Jingshang Cosmetics CGMP Issues

FDA warns Chinas Taizhou Jingshang Cosmetics Technology Co. about CGMP violations in its production of finished drugs.

latest-news-card-1
Marketing

FDA Hits Mayne Nextstellis Professional Presentation

The CDER Office of Prescription Drug Promotion hits Mayne Pharma over a professional presentation on Nextstellis that it says makes false and misleadi...

latest-news-card-1
Human Drugs

GSK, iTeos Therapeutics Scrap Lung Cancer Candidate

GSK and iTeos Therapeutics decide to stop the development of belrestotug, an anti-TIGIT monoclonal antibody for treating certain non-small cell lung c...

latest-news-card-1
Human Drugs

FDA Needs GLP-1 Long-Range Plan: Kessler

Former FDA commissioner David Kessler, who is taking one of the new weight loss drugs, calls on FDA to require data to help people come off the drugs ...

Medical Devices

Capillary Bio Wearable Infusion Set Cleared

FDA clears a Capillary Biomedical 510(k) for its SteadiSet, a wearable infusion set that delivers insulin from a pump to the body for up to three days...

latest-news-card-1
Medical Devices

GEs Optison OKd for Pediatric Heart Imaging

FDA approves GE HealthCares ultrasound imaging agent Optison 9 for use in pediatric patients.

latest-news-card-1
Human Drugs

Indian API Maker Hit with Warning Letter

FDA sends Indian active pharmaceutical ingredient manufacturer Mentha & Allied Products a Warning Letter that cites the firm for significant GMP viola...

latest-news-card-1

FDA Wants Public Deregulation Input

FDA and HHS ask public stakeholders for their ideas on regulations that should be eliminated.